Protara Therapeutics, Inc. (TARA)
3.83
+0.04
(+1.06%)
USD |
NASDAQ |
Sep 11, 16:00
3.83
0.00 (0.00%)
After-Hours: 16:54
Protara Therapeutics Gross Profit (TTM) : -0.343M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.343M |
| March 31, 2026 | -0.369M |
| December 31, 2025 | -0.625M |
| September 30, 2025 | -0.614M |
| June 30, 2025 | -0.61M |
| March 31, 2025 | -0.595M |
| December 31, 2024 | -0.332M |
| September 30, 2024 | -0.357M |
| June 30, 2024 | -0.38M |
| March 31, 2024 | -0.717M |
| December 31, 2023 | -0.711M |
| September 30, 2023 | -0.678M |
| June 30, 2023 | -0.635M |
| March 31, 2023 | -0.61M |
| December 31, 2022 | -0.93M |
| September 30, 2022 | -0.856M |
| June 30, 2022 | -0.792M |
| March 31, 2022 | -0.452M |
| December 31, 2021 | -0.087M |
| September 30, 2021 | -0.151M |
| June 30, 2021 | -0.1992M |
| March 31, 2021 | -0.1584M |
| December 31, 2020 | -0.196M |
| September 30, 2020 | -0.148M |
| June 30, 2020 | -0.0998M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0856M |
| December 31, 2019 | -0.016M |
| September 30, 2019 | -0.032M |
| June 30, 2019 | -0.054M |
| March 31, 2019 | -0.083M |
| December 31, 2018 | -0.115M |
| September 30, 2018 | -0.116M |
| June 30, 2018 | -0.132M |
| March 31, 2018 | -0.14M |
| December 31, 2017 | -0.148M |
| September 30, 2017 | -0.151M |
| June 30, 2017 | -0.148M |
| March 31, 2017 | -0.139M |
| December 31, 2016 | -0.123M |
| September 30, 2016 | -0.111M |
| June 30, 2016 | -0.092M |
| March 31, 2016 | -0.073M |
| December 31, 2015 | -0.057M |
| September 30, 2015 | -0.042M |
| June 30, 2015 | -0.026M |
| March 31, 2015 | -0.023M |
| December 31, 2014 | -0.022M |
| September 30, 2014 | -0.013M |
| June 30, 2014 | -0.02M |
| March 31, 2014 | -0.022M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| NovelStem International Corp. | 0.00 |
| Brainstorm Cell Therapeutics, Inc. | -0.179M |
| Summit Therapeutics, Inc. | -0.174M |
| Kezar Life Sciences, Inc. | -0.693M |
| Clene, Inc. | -1.295M |